The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT

Climacteric

Volumn 9, Issue 2, 2006, Pages 135-145

  Fentiman, I S ^a   Allen, D ^a   Wheeler, M ^b   Rymer, J ^c  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Breast cancer; Estradiol; Hormone replacement therapy; Menopausal symptoms; Progesterone

Indexed keywords

ESTRADIOL; HORMONE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREATHING DISORDER; COHORT ANALYSIS; DISEASE SEVERITY; DIZZINESS; EXPOSURE; FATIGUE; FEMALE; HEADACHE; HEART BEAT; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MOOD DISORDER; MYALGIA; NERVOUSNESS; NIGHT SWEAT; PANIC; PARESTHESIA; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOIMMUNOASSAY; RISK FACTOR; SEXUAL BEHAVIOR; SLEEP DISORDER; VAGINAL DRYNESS; VASOMOTOR DISORDER;

ADULT; COHORT STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGESTERONE; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 33646487000     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600674184     Document Type: Article

References (15)

1. Velasco E, Malacara JM, Cervantes F, Diaz de León J, Dávalos G, Castillo J. Gonadotropins and prolactin serum levels during the perimenopausal period: correlation with diverse factors. Fertil Steril 1990;53:56-60
2. Huerta MR, Mena A, Malacara JM, Diaz de León J. Symptoms at perimenopausal period: its association with attitudes towards sexuality, lifestyle family function and FSH levels. Psychoneuroendocrinology 1995;20:135-48
3. Øverlie I, Moen MH, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 2002;41:68-77
4. Slopien R, Maczekalski B, Warenik-Symankiewicz A. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric 2003;6:53-7
5. Malacara JM, Pérez-Luque EL, Martinez-Garza S, Sánchez-Marin FJ. The relationship of estrogen receptor-α polymorphism with symptoms and other characteristics in postmenopausal women. Maturitas 2004;49:163-9
6. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33
7. Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-27
8. Mohr PE, Wang DY, Gregory WM, Richards MA, Fentiman IS. Serum progesterone and prognosis in operable breast cancer. Br J Cancer 1996;73:1552-5
9. Fentiman IS, Wang DY, Allen DS, et al. Bone density of normal women in relation to endogenous and exogenous oestrogens. Br J Rheumatol 1994;33:808-15
10. Aksel S, Schomberg DW, Tyrey L, Hammond CB. Vasomotor symptoms, serum estrogens and gonadotrophin levels in surgical menopause. Am J Obstet Gynecol 1976;126:165-9
11. Hutton JD, Jacobs HS, Murray MA, James VA. Relation between plasma estrone and estradiol and climacteric symptoms. Lancet 1978;i:678-81
12. Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of serum follicle stimulating hormone, estradiol, and the dimeric inhibins during the menopause transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84:4025-30
13. Kasuga M, Makita K, Ishitani K, et al. Relation between climacteric symptoms and ovarian hypofunction in middle-aged and older Japanese women. Menopause 2004;11:631-8
14. Guthrie JR, Dennerstein N, Taffe JR, Lehert P, Burger HD. The menopause transition: a 9-year prospective population-based study. Climacteric 2004:7:275-89
15. Randolph JF, Sowers M, Bondarenka I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopause transition. J Clin Endocrinol Metab 2005;90:6106-12